Phenylmethylenehydantoins
J ournal of Medicinal Chemistry, 2004, Vol. 47, No. 6 1535
1990, 42 (3), 223-286. (b) Keith, D. A. Side effects of Diphenyl-
hydantoin: A Review. J . Oral Surg. 1978, 36, 206-209. (c)
Finnell, R. H. Phenytoin-induced Teratogenesis: A Mouse Model.
Science 1981, 211, 483-484.
(9) (a) Tan, S. F.; Ang, K. P.; Fong, Y. F. (Z)- and (E)-5-Arylmeth-
ylenehydantoins: Spectroscopic Properties and Configuration
Assignment. J . Chem. Soc., Perkin Trans. 2 1986, 1941-1944.
(b) Kleinpeter, K. The Structure of Hydantoins in Solution and
in the Solid State. Struct. Chem. 1997, 8 (2), 161-173.
(10) (a) Winiwarter, S.; Bonham, N. M.; Ax, F.; Anders, H.; Lenner-
nas, H.; Karlen, A. Correlation of Human J ejunal Permeability
(in Vivo) of Drugs with Experimentally and Theoretically
Derived Parameters. A Multivariate Data Analysis Approach.
J . Med. Chem. 1998, 41, 4939-4949. (b) Liu, M.; Wilairat, P.;
Go, M. L. Antimalarial Alkoxylated and Hydroxylated Chal-
cones: Structure-Activity Relationship Analysis. J . Med. Chem.
2001, 44, 4443-4452.
(5) (a) Mehta, N. B.; Diuguid, C. A. R.; Soroko, F. E. Potential
Anticonvulsants. 1. 5-Benzylhydantoins. J . Med. Chem. 1981,
24, 465-468. (b) Cortes, S.; Liao, Z. K.; Watson, D.; Kohn, H.
Effect of Structural Modification of the Hydantoin Ring on
Anticonvulsant Activity. J . Med. Chem. 1985, 28 (5), 601-606.
(c) Poupaert, J . H.; Vandervorst, D.; Guiot, P.; Mustafa, M. M.
M.; Dumont, P. Structure-Activity Relationships of Phenytoin-
like Anticonvulsant Drugs. J . Med. Chem. 1984, 27, 76-78. (d)
Krall, R. L.; Penry, J . K.; White, B. G.; Kupfergerg, H. J .;
Swinyard, E. A. Antiepileptic drug development: II. Anticon-
vulsant Drug Screening. Epilepsia 1978, 19, 409-428. (e)
Brouillette, W. J .; J estkov, V. P.; Brown, M. L.; Akhtar, M. S.;
(11) (a) Bardel, P.; Bolanos, A.; Kohn, H. Synthesis and Anticonvul-
sant Activities of R-Acetamido-N-benzylacetamide Derivatives
Containing an Electron-Deficient R-Heteroaromatic Substituent.
J . Med. Chem. 1994, 37, 4567-4571. (b) Lien, E. J .; Tong, G.
L.; Chou, J . T.; Lien, L. L. Structural Requirements for Centrally
Acting Drugs I. J . Pharm. Sci. 1973, 62 (2), 246-250. (c) Farrar,
V. A. Rutkowska, M. C.; Grochowski, J .; Serda, P.; Pilati, T.;
Filippini, G.; Hinko, C. N.; El-Assadi, A.; Moore, J . A.; Edafiagho,
I. O.; Andrews, C. W.; Cory, M.; Nicholson, J . M.; Scott, K. R.
Synthesis and CLOGP Correlation of Imidooxy Anticonvulsants.
J . Med. Chem. 1993, 36 (23), 3517-3525. (d) Seydal, J . K.;
Schaper, K. J .; Coats, E. A.; Cordes, H. P.; Emig, P.; Engel, J .;
Kutscher, B.; Polymeropoulos, E. E. Synthesis and Quantitative
Structure-Activity Relationships of Anticonvulsant 2,3,6-Tri-
aminopyridines. J . Med. Chem., 1994, 37 (19), 3016-3022,
3289-3293. (e) Lapszewicz, D.; Lange, J .; Rump, S.; Walczyna,
K.; Quantitative Structure-Activity Relationship in Anticon-
vulsants. A QSAR Analysis of New Phenylsuccinimide Deriva-
tives. Eur. J . Med. Chem. Chim. Ther. 1978, 13 (5), 465-468.
(12) (a) Tan, S. F.; Ang, K. P.; J ayachandran, H.; Fong, Y. F.
Substituent Effects in 1H and 13C Nuclear Magnetic Resonance
Correlations of Chemical Shifts in para-Substituted 5-Arylmeth-
ylenehydantoins. J . Chem. Soc., Perkin Trans. 2 1987, 11, 1043-
1045. (b) Tan, S. F.; How, G. F.; Yeoh, P. T. Synthesis and NMR
Study of 5-Furylmethylenehydantoins and 5-Thienylmethylene-
hydantoins. J . Phys. Org. Chem. 1991, 4, 681-688. (c) Tan, S.
F.; Ang, K. P.; How, G. F. NMR Spectroscopic Study of Configu-
rations and Conformations of 5-Pyridylmethylenehydantoins. J .
Phys. Org. Chem. 1990, 3, 559-566. (d) Tan, S. F.; Yong, P. L.
A.; Lee, L. T. Z-E Isomerism of 5-Cyclohexylmethylenehydan-
toins. J . Phys. Org. Chem. 1992, 5, 795-802. (e) Fresneau, P.;
Thomasson, F.; Morand, J . M.; Cussac, M. Determination of the
Stereochemistry of Substituted 5-Methylenehydantoins and
Thiohydantoins by Carbon-13 NMR and Homonuclear NOE
Experiments. Spectrosc. Lett. 1993, 26 (8), 1511-1521. (f)
Namjoshi, V. G.; Dutt, S. J . Indian J . Chem. Soc. 1931, 8, 241-
246.
DeLorey, T. M.; Brown, G. B. Bicyclic Hydantoins with
a
Bridgehead Nitrogen. Comparison of Anticonvulsant Activities
with Binding to the Neuronal Voltage-Dependent Sodium Chan-
nel. J . Med. Chem. 1994, 37, 3289-3293. (f) Brown, M. L.;
Brown, G. B. Brouillette, W. J . Effect of Phenyl Ring Conforma-
tion on the Binding of 5-Phenylhydantoins to the Voltage-
Dependent Sodium Channel. J . Med. Chem. 1997, 40, 602-607.
(g) Kwon, C. H.; Iqbal, M. T.; Wurpel, J . N. D. Synthesis and
Anticonvulsant Activity of 2-Iminohydantoins. J . Med. Chem.
1991, 34, 1845-1849.
(6) (a) Wong, P. T. H.; Tan, S. F. Pharmacological Profiles of
5-Phenylmethylenehydantoin and Its Methoxy Substituted De-
rivatives. J pn. J . Pharmacol. 1989, 49 (3), 309-315. (b) Wong,
P. T. H.; Tan, S. F. N-Demethylation of Methyl and Dimethyl
Derivatives of Phenytoin and Their Anticonvulsant Activities
in Mice. J pn. J . Pharmacol. 1988, 48 (4), 473-478. (c) Wong, P.
T. H.; Tan, S. F.; Teo, W. L. Testing for Anticonvulsant Activities
of Derivatives of Phenytoin and 5-Phenylmethylenehydantoin.
Asia Pac. J . Pharmacol. 1989, 4, 107-112.
(7) van der Waterbeemd, H. Quantitative Approaches to Structure
Activity Relationships. In The Practice of Medicinal Chemistry;
Wermuth, C. G., Ed.; Academic Press: London, 1996; p 367.
(8) (a) Tasso, S. M.; Bruno-Blanch, L. E.; Moon, S. C.; Estiu, G. L.
Pharmacophore Searching and Quantitative Analysis in the
Design of Anticonvulsant Drugs. J . Mol. Struct.: THEOCHEM
2000, 504, 229-240. (b) Weaver, D. F.; Sutherland, J . F.
Development of Quantitative Structure Activity Relationships
and Classification Models for Anticonvulsant Activity of Hydan-
toin Analogues. J . Chem. Inf. Comput. Sci. 2003, 43 (3), 1028-
1036. (c) Murray, J . S.; Abu-Awwad, F.; Politzer, P.; Wilson, L.
C.; Toupan, A. S.; Wall, R. E. Molecular Surface Electrostatic
Potentials of Anticonvulsant Drugs. Int. J . Quantum Chem.
1998, 70 (6), 1137-1143. (d) Hadjipavlou-Litina, D. Review,
Reevaluation, and New Results in Quantitative Structure-
Activity Studies of Anticonvulsants. Med. Res. Rev. 1998, 18 (2),
91-119. (e) Scholl, S.; Koch, A.; Henning, D.; Kempter, G.;
Kleinpeter, E. The Influence of Structure and Lipophilicity of
Hydantoin Derivatives on Anticonvulsant Activity. Struct. Chem.
1999, 10, 355-366. (f) Lien, E. J . Structure Activity Correlations
of Anticonvulsant Drugs. J . Med. Chem. 1970, 13 (6), 1189-
1191. (g) Codding, P. W.; Lee, T. A.; Richardson, J . F. Cyhep-
tamide and Hydroxy-3-phenacyloxyindole: Structural Similarity
to Diphenylhydantoin as the Basis for Anticonvulsant Activity.
J . Med. Chem. 1984, 27, 649-654. (h) Camerman, A.; Camer-
man, N. Diphenylhydantoin and Diazepam: Molecular Structure
Similarities and Steric Basis of Anticonvulsant Activity. Science
1970, 1457-1458.
(13) (a) Wernly Chung, G. N.; Mayer, J . M.; Tsantili-Kakoulidou, A.;
Testa, B. Structure-Reactivity Relationships in the Chemical
Hydrolysis of Prodrug Ester of Nicotinic Acid. Int. J . Pharm.
1990, 63, 129-134. (b) Rong, X.; Go, M. L.; Structure-Hydro-
lyzability Relationships in a Series of Piperidinyl and Tropinyl
Esters with Antimuscarinic Activity. Chem. Pharm. Bull. 1997,
45, 476-481.
(14) SIMCA; Umetrics AB (Box 7960, S-907 19): Umea, Sweden,
1999.
J M030450C